Eli Lilly Urges Full Fed. Circ. To Scrap Teva's $177M IP Win
By Dorothy Atkins · June 17, 2026, 10:55 PM EDT
Eli Lilly & Co. urged the full Federal Circuit Wednesday to review a panel ruling that upheld Teva's $177 million jury verdict on headache drug patents, arguing that the panel's decision...
To view the full article, register now.